The curative action of hexamethylmelamine on intramuscularly or intracerebrally implanted Yoshida sarcoma.

Abstract

Curative effects of hexamethylmelamine (HMM, NSC 13875) against intramuscularly or intracerebrally implanted Yoshida sarcoma depend on the schedules. A twice daily oral administration over a 2-week period showed a significant chemotherapeutic advantage over a single daily administration. The observed curative effect depends on the tumour site and on its… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.